Search Thermo Fisher Scientific
Search Thermo Fisher Scientific
OncoPro Tumoroid Cell Lines |
Kick-off your 3D cancer research workflow with our Gibco OncoPro Tumoroid Cell Lines. Also referred to as cancer organoid cell lines, these models are established from primary patient tissues and have been fully characterized. Each of our tumoroid cell lines were derived and expanded in our Gibco OncoPro Tumoroid Culture Medium, and are accompanied by detailed protocols and resources to help with adoption and integration into your research workflow.
When cultured in OncoPro Tumoroid Culture Medium, OncoPro Tumoroid Cell Lines help support quality 3D cancer research since these lines are:
Tumoroid line | Diagnosis - Stage | Tumor site | Race Sex, Age | Height (in), Weight (lb) | Treatment status |
---|---|---|---|---|---|
HuCo031721 | Colorectal adenocarcinoma - IIA | Transverse colon | White Male, 82 | 70", 260 lb | Pre-Treatment |
HuCo111622 | Colorectal adenocarcinoma - IIA | Rectum | White Female, 70 | 63", 215 lb | Pre-Treatment |
HuCo083123 | Colorectal adenocarcinoma - IIIC | Rectosigmoid | White Male, 46 | 70", 248 lb | Pre-Treatment |
HuCo090123 | Poorly differentiated adenocarcinoma - IIA | Colon | African-American Female, 90 | 63", 138 lb | Pre-Treatment |
HuCo100523 | Colorectal adenocarcinoma - IIA | Ascending colon | White Female, 85 | 62", 148 lb | Pre-Treatment |
HuCo052121 | Colorectal adenocarcinoma - IIA | Rectum | White Female, 46 | 60", 154 lb | Pre-Treatment |
HuLu051421 | NSCLC, Squamous cell carcinoma - IA3 | Middle lobe of lung | White Male, 63 | 75", 209 lb | Pre-Treatment |
HuLu051921 | NSCLC, Large cell carcinoma - IIA | Upper lobe of lung | White Female, 69 | 67", 169 lb | Pre-Treatment |
HuBr102622 | Invasive ductal carcinoma, ductal carcinoma in situ present - IA | Breast | White Female, 56 | 63", 131 lb | Pre-Treatment |
HuEn061022 | Endometrioid Carcinoma - IA | Endometrium | White Female, 67 | 65", 162 lb | Pre-Treatment |
HuEn070722 | Dedifferentiated carcinoma - IIIC1 | Endometrium, lower uterine segment | White Female, 76 | 66", 272 lb | Pre-Treatment |
HuEn041521 | Endometrioid Carcinoma - IIIC1 | Endometrium | White Female, 78 | 60", 189 lb | Pre-Treatment |
HuEn022222 | Endometrioid carcinoma - IA | Endometrium | White Female, 58 | 62", 150 lb | Pre-Treatment |
HuEn033122 | Endometrioid carcinoma - IA | Endometrium | White Female, 59 | 64", 200 lb | Pre-Treatment |
Explore relevant data that demonstrate the quality and consistency of OncoPro Tumoroid Cell Lines. In-depth characterization data is available for each tumoroid cell line upon request by completing an inquiry form.
Figure 1. Tumoroid cell lines preserve donor-specific mutations. Unique genomic mutations are preserved between primary tumors and established tumoroid cultures. Next-generation sequencing (Oncomine Comprehensive Assay v3) was used to identify single-base substitutions (bar graphs), oncogenic mutations, and copy number variations (heat map).
Figure 3. Tumoroid lines grow consistently in an easy-to-use, scalable format.(A) Expansion rates of tumoroids in suspension culture in OncoPro medium. Number of cells counted after thawing from cryopreservation (day 0) and at each passage. (B) Individual samples have consistent growth rates and can typically generate 100 million viable cells within 30 or 60 days.
Visit our tumoroid webpage to learn about these models and how they can be utilized in cancer research.
Discover an off-the-shelf tumoroid culture medium that simplifies tumoroid culture.
Learn how our team of experts can help tumoroid researchers with workflow optimization, transition support, and more.
For Research Use Only. Not for use in diagnostic procedures.